In vivo evidence for mTORC2-mediated actin cytoskeleton rearrangement in neurons

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• The mammalian target of rapamycin (mTOR) forms two complexes: mTORC1 and mTORC2.
• mTORC1 regulates cell growth pathways, while mTORC2's physiological roles are less understood.
• Recent studies investigate mTORC2's function in the central nervous system.

Purpose of the Study:

• To comment on recent findings regarding the role of mTORC2 in the brain.
• To explore the implications of mTORC2 deficiency in neuronal function and morphology.
• To discuss the potential link between mTORC2 signaling and neurological diseases.

Main Methods:

• Review of recent gene-targeted mouse studies.
• Analysis of phenotypes in mice lacking mTORC2 in specific brain regions (cerebellum, hippocampus).
• Discussion of molecular mechanisms, including actin cytoskeleton regulation and PKC isoform activation.

Main Results:

• Gene-targeted mice lacking mTORC2 in the cerebellum or hippocampus exhibit significant defects in neuron morphology.
• Synapse function is impaired in these mTORC2-deficient mice.
• Perturbed actin cytoskeleton regulation and reduced PKC isoform activation are implicated in the observed phenotype.

Conclusions:

• mTORC2 plays a critical role in maintaining normal neuron morphology and synapse function.
• Aberrant mTORC2 signaling may contribute to neurological conditions, including spinocerebellar ataxia.
• Further research into mTORC2 pathways could reveal new therapeutic targets for brain diseases.